Trial Profile
A Randomized, Placebo-Controlled, Double-Blind Trial of Duloxetine in the Treatment of Patients With Chronic Fatigue Syndrome
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Chronic fatigue syndrome
- Focus Therapeutic Use
- Acronyms CFS
- 24 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 01 Apr 2014 New trial record
- 02 Jul 2012